This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignee: Dong-A St Co., Ltd.. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Title: Innovations of Jung-Sang Park
Introduction
Jung-Sang Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with antibacterial properties. With a total of three patents to his name, his work has the potential to impact the treatment of various bacterial infections and other medical conditions.
Latest Patents
One of Jung-Sang Park's latest patents involves tetrahydropyridine derivatives and their use as antibacterial agents. This patent discloses a novel tetrahydropyridine derivative compound, methods for preparing these compounds, and their application in treating Gram-negative bacterial infections. The compounds can exhibit excellent effects on bacterial infections, making them valuable in therapeutic settings.
Another significant patent focuses on biphenyl derivatives and methods for preparing them. These biphenyl derivatives act as muscarinic M3 receptor antagonists, which can be useful in treating a range of diseases, including chronic obstructive pulmonary disease, asthma, and Alzheimer's disease. The versatility of these compounds highlights Jung-Sang Park's innovative approach to pharmaceutical development.
Career Highlights
Jung-Sang Park is currently associated with Dong-a St Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the pharmaceutical industry, and his patents reflect a commitment to addressing critical health challenges through innovative solutions.
Collaborations
Jung-Sang Park collaborates with talented individuals in his field, including Weon-Bin Im and Sung-Hak Choi. These collaborations enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Jung-Sang Park's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare solutions. His work in developing novel compounds has the potential to significantly impact the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile